FDA Adverse Event Malfunction Summary report: N

BD PHASEAL¿ INFUSION SET (C61)

MDR report key: 8524267 · Received April 17, 2019

Report

Report Number
2243072-2019-00743
Event Type
Malfunction
Date Received
April 17, 2019
Date of Event
April 2, 2019
Report Date
May 9, 2019
Manufacturer
BECTON DICKINSON
Product Code
FPA
PMA / PMN Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION: DHR REVIEW WAS DONE AND NO ISSUES WERE REPORTED DURING PRODUCTION OF THIS LOT. NO SAMPLE RECEIVED FOR THIS COMPLAINT, PICTURE WAS PROVIDED. CT SCAN WAS PERFORMED ON LEAKING SAMPLE WHICH WAS SEGREGATED DURING PRODUCTION. AFTER THIS SCAN ADDITIONAL TESTS WERE DONE ON SPIKE COMPONENT AND CONCENTRICITY OF LOWER PART OF SPIKE COMPONENT CAUSED MOLDING DEFICIT ON ONE SIDE OF COMPONENT. CAPA# (B)(4) WAS INITIATED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THERE WERE 5 OCCURRENCES OF LEAKING WITH A BD PHASEAL¿ INFUSION SET (C61). THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WE HAVE HAD NOW 5 LEAKING C61¿S FOUND IN PRODUCTION FROM LOT 1011186. THIS LEAK SEEMS TO BE COMING FROM NEAR THE WELD POINT AND THE MAIN PLASTIC BODY.

Additional Manufacturer Narrative · 1

FOR OEM MANUFACTURING SITES: IN THIS MDR, BD CORPORATE HEADQUARTERS IN (B)(4) HAS BEEN LISTED AS (B)(4) IS AN OEM MANUFACTURING SITE. (B)(6). A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THERE WERE 5 OCCURRENCES OF LEAKING WITH A BD PHASEAL¿ INFUSION SET (C61). THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WE HAVE HAD NOW 5 LEAKING C61¿S FOUND IN PRODUCTION FROM LOT 1011186. THIS LEAK SEEMS TO BE COMING FROM NEAR THE WELD POINT AND THE MAIN PLASTIC BODY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
318550 BD PHASEAL¿ INFUSION SET (C61) ADMINISTRATION SET FPA BECTON DICKINSON 1011186

Patients

Seq Age Sex Outcome Treatment
1 Other